The alternative complement pathway with location of several sites of genetic defects (asterisk) and site of action of Eculizumab.
Abbreviations: aHUS, atypical hemolytic uremic syndrome; C3aR, C3a receptor; C5aR, C5a receptor; MAC, membrane attack complex.